Go Pro
→ Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown” (From Paradigm Press) (Ad)tc pixel Free OCEAW Stock Alerts

Ocean Biomedical (OCEAW) Competitors

Compare

OCEAW vs. SXTPW, BFRIW, CINGW, CLVR, and CMRAW

Should you buy Ocean Biomedical stock or one of its competitors? Ocean Biomedical's main competitors and comparable companies include 60 Degrees Pharmaceuticals (SXTPW), Biofrontera (BFRIW), Cingulate (CINGW), Clever Leaves (CLVR), and Comera Life Sciences (CMRAW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Ocean Biomedical compare to 60 Degrees Pharmaceuticals?

Ocean Biomedical (NASDAQ:OCEAW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, profitability, analyst recommendations, dividends, media sentiment and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ocean BiomedicalN/AN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.11MN/AN/AN/AN/A

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than Ocean Biomedical. MarketBeat recorded 1 mentions for 60 Degrees Pharmaceuticals and 0 mentions for Ocean Biomedical. 60 Degrees Pharmaceuticals' average media sentiment score of 1.99 beat Ocean Biomedical's score of 0.00 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
Ocean Biomedical Neutral
60 Degrees Pharmaceuticals Very Positive

Company Net Margins Return on Equity Return on Assets
Ocean BiomedicalN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

Summary

60 Degrees Pharmaceuticals beats Ocean Biomedical on 3 of the 3 factors compared between the two stocks.

How does Ocean Biomedical compare to Biofrontera?

Ocean Biomedical (NASDAQ:OCEAW) and Biofrontera (NASDAQ:BFRIW) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, institutional ownership, profitability, valuation, dividends, earnings and risk.

Company Net Margins Return on Equity Return on Assets
Ocean BiomedicalN/A N/A N/A
Biofrontera N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ocean BiomedicalN/AN/AN/AN/AN/A
Biofrontera$46.18MN/AN/AN/AN/A

In the previous week, Ocean Biomedical's average media sentiment score of 0.00 equaled Biofrontera'saverage media sentiment score.

Company Overall Sentiment
Ocean Biomedical Neutral
Biofrontera Neutral

Summary

Biofrontera beats Ocean Biomedical on 1 of the 1 factors compared between the two stocks.

How does Ocean Biomedical compare to Cingulate?

Cingulate (NASDAQ:CINGW) and Ocean Biomedical (NASDAQ:OCEAW) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, risk, media sentiment, profitability and earnings.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CingulateN/AN/AN/AN/AN/A
Ocean BiomedicalN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
CingulateN/A N/A N/A
Ocean Biomedical N/A N/A N/A

In the previous week, Cingulate's average media sentiment score of 0.00 equaled Ocean Biomedical'saverage media sentiment score.

Company Overall Sentiment
Cingulate Neutral
Ocean Biomedical Neutral

Summary

Cingulate and Ocean Biomedical tied by winning 0 of the 0 factors compared between the two stocks.

How does Ocean Biomedical compare to Clever Leaves?

Clever Leaves (NASDAQ:CLVR) and Ocean Biomedical (NASDAQ:OCEAW) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings, media sentiment and profitability.

Company Net Margins Return on Equity Return on Assets
Clever LeavesN/A N/A N/A
Ocean Biomedical N/A N/A N/A

6.9% of Clever Leaves shares are held by institutional investors. 8.2% of Clever Leaves shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Ocean Biomedical has lower revenue, but higher earnings than Clever Leaves.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clever Leaves$17.42M0.00-$17.90M-$9.66N/A
Ocean BiomedicalN/AN/AN/AN/AN/A

In the previous week, Clever Leaves' average media sentiment score of 0.00 equaled Ocean Biomedical'saverage media sentiment score.

Company Overall Sentiment
Clever Leaves Neutral
Ocean Biomedical Neutral

Summary

Clever Leaves beats Ocean Biomedical on 3 of the 3 factors compared between the two stocks.

How does Ocean Biomedical compare to Comera Life Sciences?

Comera Life Sciences (NASDAQ:CMRAW) and Ocean Biomedical (NASDAQ:OCEAW) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, valuation, dividends, risk, media sentiment and earnings.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Comera Life Sciences$1.00MN/AN/AN/AN/A
Ocean BiomedicalN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Comera Life SciencesN/A N/A N/A
Ocean Biomedical N/A N/A N/A

In the previous week, Comera Life Sciences' average media sentiment score of 0.00 equaled Ocean Biomedical'saverage media sentiment score.

Company Overall Sentiment
Comera Life Sciences Neutral
Ocean Biomedical Neutral

Summary

Comera Life Sciences beats Ocean Biomedical on 1 of the 1 factors compared between the two stocks.

Get Ocean Biomedical News Delivered to You Automatically

Sign up to receive the latest news and ratings for OCEAW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OCEAW vs. The Competition

Export
MetricOcean BiomedicalPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$11.86B$7.04B$12.87B
Dividend YieldN/A2.59%2.54%9.14%
P/E RatioN/A784.68271.1525.40
Price / SalesN/A761.30625.5291.17
Price / CashN/A15.1828.9235.62
Price / BookN/A11.0010.926.42
Net IncomeN/A$2.81B$3.48B$358.18M

Ocean Biomedical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OCEAW
Ocean Biomedical
N/AN/AN/AN/A$0.00N/AN/A2
SXTPW
60 Degrees Pharmaceuticals
N/A$0.03
flat		N/A-50.7%$0.00$1.11MN/A2
BFRIW
Biofrontera
N/A$0.02
-10.0%		N/A-80.0%$0.00$46.18MN/A70
CINGW
Cingulate
N/A$0.01
+1.1%		N/A-83.7%$0.00N/AN/A20
CLVR
Clever Leaves
N/A$0.00
flat		N/AN/A$0.00$17.42MN/A560

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:OCEAW) was last updated on 9/8/2026 by MarketBeat.com Staff.
From Our Partners
Moderna’s 177% Surge Puts Cancer Biotech Back in Focus
Moderna shares surged 177% in a single trading session on August 19, adding about $45 billion in market value ...
The Tomorrow Investor | Sponsoredtc pixel
This looks like plywood. It's not.
AI data centers have a power problem nobody likes to talk about. A single rack of computers can now use more e...
Eagle Publishing | Sponsoredtc pixel
SpaceX pays a 10X launch penalty
SpaceX burns roughly $200,000 in fuel per Falcon 9 launch - about $20 million across 100 missions. One unde...
Freedom Financial | Sponsoredtc pixel
The trade I’ve been waiting for since 2011
Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...
Traders Agency | Sponsoredtc pixel
This weekend trading strategy could change your Mondays
Every Monday, trader Tim Sykes opens his account to potential profits as high as $8,780, $9,177, even $16,000....
Tim Sykes | Sponsoredtc pixel
Musk just exposed the crack in his empire
SpaceX's IPO raised approximately $85.7 billion in gross proceeds. Days later, the company revealed its combin...
The Oxford Club | Sponsoredtc pixel
BlackRock and Vanguard already own THIS
Institutions own roughly 88 percent of an overlooked American oil and natural gas company. BlackRock holds 32 ...
Monument Traders Alliance | Sponsoredtc pixel
They're not buying gold. They're buying this.
Bank of America raised its stake in a small gold company by 139%. Jane Street increased its position by 159%, ...
Behind the Markets | Sponsoredtc pixel